Duloxetine HCL EC Pellets-Suitable for filling 20mg, 40mg & 60mg Capsules.

  • Release pattern compared with innovator
  • MKPPL objective is to develop duloxetine pellets by aqueous technology. Pellets developed by aqueous technology have advantage of avoiding the use of organic solvents.
  • All the ingredients are available for both FBC process and all the equipment’s including analytical instruments like HPLC, FTIR, GC and dissolution apparatus are available to develop duloxetine pellets.
  • Offer complete technical package for registrations in all regulated/semi regulated markets.

Additional information

17%, 20%

Release Type

Delayed Release

Target Formulations


Documentation Available:

DMF in CTD Format

Privacy Preference Center